The company anticipates clinical timelines for HS-410 to remain materially unchangedDURHAM, N.C., Feb. 03, ...
Mass cytometry services for pharmaceutical and biotechnology companies to accelerate development of new health ...
WATERTOWN, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty biopharmaceutical ...
